Adamis Pharma

ADMP NASDAQ
1.080
0.000
0.00%
Closed 16:00 08/19 EDT
Open
1.080
Prev Close
1.080
High
1.120
Low
1.040
Volume
719.20K
Avg Vol (3M)
482.56K
52 Week High
4.250
52 Week Low
0.9250
% Turnover
1.16%
Market Cap
66.35M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Adamis Pharma ADMP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.
MORE >

Recently

Name
Price
%Change